Chorioamnionitis and ontogeny of circulating prostaglandin and thromboxane in preterm infants

Girija Natarajan1, Maria Glibetic, Ronald L Thomas

  • 1Division of Neonatology, Children's Hospital of Michigan and Hutzel Women's Hospital, Detroit, MI 48201, USA. gnatara@med.wayne.edu

Insights

Chorioamnionitis did not significantly alter plasma prostaglandin E2 (PGE2) and thromboxane B2 (TxB2) levels in preterm infants during the first week. Lower levels of these substances were associated with increased mortality and morbidities in neonates.

Area of Science:

  • Neonatal Medicine
  • Perinatal Biology
  • Biochemistry

Background:

  • Chorioamnionitis is a known risk factor for adverse neonatal outcomes.
  • Prostaglandin E2 (PGE2) and thromboxane B2 (TxB2) are inflammatory mediators with roles in pregnancy and birth.
  • Their specific impact on preterm infants with chorioamnionitis requires further elucidation.

Purpose of the Study:

  • To investigate the effect of chorioamnionitis on plasma concentrations of PGE2 and TxB2 in preterm infants.
  • To analyze these levels during the first week of life.
  • To correlate these levels with neonatal outcomes such as mortality and bronchopulmonary dysplasia.

Main Methods:

  • Plasma PGE2 and TxB2 were measured at 1, 3, and 7 days of age.
  • Preterm infants (birth weights 501-1500 g) were categorized based on the presence (N=26) or absence (N=22) of maternal chorioamnionitis.
  • Statistical analysis was performed to compare groups and identify associations.

Main Results:

  • Infants with chorioamnionitis had lower mean gestational age and birth weight.
  • Plasma PGE2 and TxB2 levels varied widely but did not significantly differ between groups.
  • TxB2 levels were lower in infants who died or developed morbidities.

Conclusions:

  • Circulating PGE2 and TxB2 concentrations in preterm infants are highly variable in the first week.
  • Chorioamnionitis does not appear to significantly alter these specific plasma levels.
  • Lower TxB2 concentrations may be linked to adverse neonatal outcomes, warranting further investigation.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Gonadal and Placental Hormones01:24

Gonadal and Placental Hormones

The gonads, namely the testes in males and the ovaries in females, are pivotal in producing gonadal hormones that orchestrate the intricate processes of sexual development and reproduction.
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...